Editorial

Revisiting and proposing the most important questions in cancer research and clinical oncology

¹ Department of Radiation Oncology, Guangzhou Concord Cancer Center, 9 Ciji Road, Guangzhou, Guangdong 510555, China
² Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, Level 4, Academic Block, John Radcliffe Hospital, University of Oxford, Headley Way, Headington, Oxford OX3 9DU, UK
³ Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, 268 Kai-Xuan Road, Hangzhou, Zhejiang 310029, China

^* Corresponding author: chaonan.qian@ccm.cn

Received: 16 March 2024
Accepted: 16 March 2024

Abstract

Given the limitations in our understanding of cancer development and treatment options, malignant neoplasms remain a leading cause of death worldwide. In 2016, to bolster our fight against cancer, we invited authors globally to identify the most crucial questions in cancer research and clinical oncology. This effort led to the review and publication of 101 key scientific questions, sparking a surge in promising research across various domains. With the significant growth in our knowledge and evidence over the past decade, we are excited to invite authors to revisit and refine their previously published key questions. We also encourage the submission of new key questions related to malignant diseases. The deadline for submitting these impactful questions is extended to the end of 2025.